2019
DOI: 10.1186/s12889-019-6847-5
|View full text |Cite|
|
Sign up to set email alerts
|

RETRACTED ARTICLE: The distribution and socioeconomic burden of Hepatitis C virus in South Australia: a cross-sectional study 2010–2016

Bernard Luke Edmunds,
Emma Ruth Miller,
George Tsourtos

Abstract: Background Hepatitis C virus infection (HCV) is a communicable disease of increasing global importance with 1.75 million new infections and 400,000 related deaths annually. Until recently, treatment options have had low uptake and most infected people remain untreated. New Direct Acting Antiviral medications can clear the virus in around 95% of cases, with few side-effects. These medications are restricted in most countries but freely accessible in Australia, yet most people still remain untreated… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
17
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 23 publications
(20 citation statements)
references
References 115 publications
1
17
0
Order By: Relevance
“…11 Our approach is arguably more clinically meaningful and is more suitable for economic evaluations; most modelling studies 3,4,13 include similarly defined health states. 29 Limitations of our study include that we excluded patients without valid OHIP numbers, and chronic hepatitis C disproportionately affects socioeconomically marginalized populations, 30 who may not have a permanent address from which to apply for publicly funded health insurance. We could not include costs borne by private health insurers or, more important, out-of-pocket costs paid by patients, many of whom are unable to work because of HCV infection.…”
Section: Limitationsmentioning
confidence: 99%
“…11 Our approach is arguably more clinically meaningful and is more suitable for economic evaluations; most modelling studies 3,4,13 include similarly defined health states. 29 Limitations of our study include that we excluded patients without valid OHIP numbers, and chronic hepatitis C disproportionately affects socioeconomically marginalized populations, 30 who may not have a permanent address from which to apply for publicly funded health insurance. We could not include costs borne by private health insurers or, more important, out-of-pocket costs paid by patients, many of whom are unable to work because of HCV infection.…”
Section: Limitationsmentioning
confidence: 99%
“…In high‐income countries, the HCV burden is mainly felt in marginalized populations 11 such as people who inject drugs and homeless people. In Europe, injecting drug use is the main route of HCV transmission 12 .…”
Section: Introductionmentioning
confidence: 99%
“…Another study revealed that rural population had negative attitude towards the patients of hepatitis B and C. Further results also indicated that people having low income and less education also had negative attitude towards HCV, which may be due to lack of knowledge about the disease (17). In Australia, people living in the poorest areas had high rates of unemployment and injection drug users were more likely to be infected with Hepatitis C (18). The main objective of this study was to identify the impact of socio-economic determinants on patient's knowledge, attitude and practice.…”
Section: Introductionmentioning
confidence: 99%